Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
College aantekeningen

All lecture notes for BIOL123 Infection and Immunity

Beoordeling
-
Verkocht
-
Pagina's
25
Geüpload op
05-09-2023
Geschreven in
2022/2023

25 pages covering all 12 lectures. Includes highlighted definitions. Provides specific examples required in the module. (I achieved a score of 19.7/75.6%/first in this module)

Instelling
Vak

Voorbeeld van de inhoud

Biol123 – Infection and Immunity


Contents
L1 – Global Impact of Infection diseases ................................................................................................ 1
L2 – Innate Immune System ................................................................................................................... 2
Inflammation:...................................................................................................................................... 3
Systemic Acute-Phase Response:.................................................................................................... 3
Complement Summary ................................................................................................................... 3
L3 – Adaptive Immunity .......................................................................................................................... 4
L4 – Immune Processes........................................................................................................................... 6
Humoral Response: ............................................................................................................................. 7
Cell-Mediated Immunity: .................................................................................................................... 7
Immunisation - Humoral + Cell-Mediated Response: ......................................................................... 8
L5 – Influenza Virus ................................................................................................................................. 8
L6 – Severe Acute Respiratory Syndrome Coronavirus 2 ..................................................................... 10
L7 – The Plague ..................................................................................................................................... 11
L8 – Malaria........................................................................................................................................... 13
L9 - Nematodes ..................................................................................................................................... 15
L10 – Cestodes = tapeworms ................................................................................................................ 17
Hydatid cyst = dog tapeworm ........................................................................................................... 18
L11 - Schistosomiasis ............................................................................................................................ 18
L12 - Vaccines........................................................................................................................................ 21




L1 – Global Impact of Infection diseases
Infectious agent: viruses, bacteria, fungi + parasites
Acute infections = viruses, bacteria + fungi -> symptoms develop rapidly
Chronic infections = parasites -> symptoms have slow progression
Parasites = protists + helminths
Symbiosis: an interaction between 2 different organisms living in close physical association
Types of symbiosis:
Parasitism:1 organism benefits, the other is harmed
Commensalism: 1 organism benefits, the other is neither harmed nor benefits
Mutualism: both organisms benefit

Stages of infectious disease:
1. Incubation period = time between infection + first symptoms

, 2. Prodromal period = short period of mild symptoms
3. Illness = most evident symptoms
4. Convalescence = body returns to normal, immune system fully responded
Resolution = no longer experiencing symptoms
Subclinical disease: host does not reach clinal threshold + clears disease before having a full set of
symptoms
Clinical threshold: full symptoms, disease contracted
Critical threshold: can no longer survive
Disease Progression:
1. Invasion – host transmission + entry
2. Multiplication – some multiply in body
3. Spread – from initial infection site to other areas in body
4. Pathogenesis – causation + development of clinical disease
Disease progression influenced by: number of pathogenic organisms, virulence, host reaction
Disease severity influenced by: infecting dose, age, sex, genetics…
Global burden of disease:
incidence: number of new cases in a population in a time period
Prevalence: total number of infected individuals at a point in time
Mortality: total deaths per year
Economics + Disability:
HIC – major diseases – cancer, Heart disease
LIC – infectious diseases – AIDS, tuberculosis
• Mortality does not give full picture of full burden of disease
• Morbidity: state of ill health -> lower quality of life
DALY = Disability Adjusted Life Year: measure of years lost due to premature mortality + morbidity
DALY = YLL + YLD YLL = Years of life lost YLD = Years lost to disability
DALY Disadvantages: doesn’t consider economic impacts, treatment costs, social stigma around
disease

L2 – Innate Immune System
Fighting Infection:
1. Prevent pathogen entering = innate
2. Kill/remove pathogen = innate + adaptive
3. Remember pathogen = adaptive
Blood, lymphatic system, adaptive cells
Lymphatic system = bone marrow, thymus, lymph nodes, spleen
Adaptive cells = antibodies, cytokines complement molecules

Innate Immune System: local inflammatory response + systemic acute-phase response

Mechanical Barriers:
Skin – dead cells not infected, low pH in sebaceous gland -> skin dry -> not much nutrients for
pathogen
Tight Junctions – prevent ingested antigens entering bidy
Mucosal surfaces – mucus traps organisms + is shed from body

, Physiological Barriers: low pH in stomach, Commensal bacteria, Chemical Mediators - antimicrobial
peptides + proteins (defensins), cytokines (interferons) + complement molecules (MAC)

Innate Immune System Cells:
1. Phagocytes:
Macrophages: engulf + digest pathogens – white, no nucleus, not circular
Neutrophils: internalise bacteria – multinucleated
Dendritic cells: act as APCs – lots of pseudopodia
2. Granulocytes
Basophils: release histamine, heparin + immunoglobin – largest granulocyte + many granules
Neutrophils: release chemicals to kill pathogens + can kill itself to release sticky DNA -> trap
Eosinophils: stimulate mast cells + release granules to kill parasites – bilobed nucleus
Mast cells: release heparin, serotonin + histamine – light green nucleus, dark green
cytoplasm + pink granules
3. Lymphocytes
Natural killer cells: kill infected or cancerous cells – large nucleus
Innate lymphoid cells (ILCs): secrete effector cytokines + regulate functions of other cells
Heparin: anticoagulant -> blood thinner
Histamine: increase blood vessel wall permeability
Serotonin: neurotransmitter
Immunoglobin: antibodies

Inflammation:
Symptoms: Calor, Rubor, Tumor + Dolor
Chemokines = family of cytokines
1. Damaged endothelial cells release IL-8 (Interleukin 8/ CXL8)
2. Macrophages release TNF-α (Tumour necrosis factor)
3. TNF-α + IL-8 recruit Neutrophils
4. Mast cells release histamine -> vasodilation: increase blood vessel permeability
5. TNF-α + IL-6 stimulate Systemic Acute-Phase Response
6. Clotting + complement cascade activation due to pro-inflammatory cytokines TNF- a + IL-6
7. Neutrophils secrete chemokines -> recruits monocytes
8. Phagocytosis by macrophages
9. Macrophages migrate into tissue + release IL-1 (Interleukin 1) + TNF-α
Systemic Acute-Phase Response:
Fever – increase temp -> speed up phagocytosis
Leucocytosis: increase white blood cell production
Acute-phase protein production in liver:
1. C-Reactive Protein (CRP) binds to microbes
2. Activates complement proteins -> aid phagocytosis
• Macrophages secrete IL-6 -> activates complement
• Cells produce IFNs (Type 1 interferons) + IL-8

Complement Summary
Complement system: group of serum (blood) proteins in blood, perform critical defence against
pathogens, especially in extracellular bacteria
= Soluble proteins produced by the liver

Geschreven voor

Instelling
Studie
Onbekend
Vak

Documentinformatie

Geüpload op
5 september 2023
Aantal pagina's
25
Geschreven in
2022/2023
Type
College aantekeningen
Docent(en)
Dr lucy jackson-jones
Bevat
Alle colleges

Onderwerpen

€10,72
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper
Seller avatar
gotham9059

Maak kennis met de verkoper

Seller avatar
gotham9059 Lancaster University
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
-
Lid sinds
2 jaar
Aantal volgers
0
Documenten
12
Laatst verkocht
-
Lancaster Biology Notes

Received an average aggregated score of 18.7/72.5%/first in first year. Selling notes from first year.

0,0

0 beoordelingen

5
0
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen